BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8388821)

  • 1. Genetic stability and instability of the cis-acting control element of the 5' untranslated region of the poliovirus RNA.
    Agol VI
    Dev Biol Stand; 1993; 78():11-6. PubMed ID: 8388821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
    Minor PD; Macadam AJ; Stone DM; Almond JW
    Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.
    Taffs RE; Chumakov KM; Rezapkin GV; Lu Z; Douthitt M; Dragunsky EM; Levenbook IS
    Virology; 1995 Jun; 209(2):366-73. PubMed ID: 7778271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation and reversion of the Sabin vaccine strains of poliovirus.
    Minor PD
    Dev Biol Stand; 1993; 78():17-26. PubMed ID: 8388828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards development of an in vitro translation test for poliovirus neurovirulence.
    Svitkin YV; Alpatova GA; Lipskaya GA; Maslova SV; Agol VI; Kew O; Meerovitch K; Sonenberg N
    Dev Biol Stand; 1993; 78():27-32. PubMed ID: 8388829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence.
    Chumakov K; Norwood L; Parker M; Dragunsky E; Taffs R; Ran Y; Ridge J; Levenbook I
    Dev Biol Stand; 1993; 78():79-89; discussion 88-9. PubMed ID: 8388834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution and polymorphism of poliovirus genomes.
    Crainic R; Kew O
    Biologicals; 1993 Dec; 21(4):379-84. PubMed ID: 8024754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.
    Burns CC; Shaw J; Campagnoli R; Jorba J; Vincent A; Quay J; Kew O
    J Virol; 2006 Apr; 80(7):3259-72. PubMed ID: 16537593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutations in oral poliovirus vaccine by hybridization with generic oligonucleotide microchips.
    Proudnikov D; Kirillov E; Chumakov K; Donlon J; Rezapkin G; Mirzabekov A
    Biologicals; 2000 Jun; 28(2):57-66. PubMed ID: 10885613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
    Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
    Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An authentic 3' noncoding region is necessary for efficient poliovirus replication.
    Brown DM; Cornell CT; Tran GP; Nguyen JH; Semler BL
    J Virol; 2005 Sep; 79(18):11962-73. PubMed ID: 16140772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral sequences required for neurovirulence of poliovirus.
    Racaniello VR
    Bioessays; 1986 Dec; 5(6):266-70. PubMed ID: 3032167
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.
    Minor PD; Dunn G; Ramsay ME; Brown D
    J Med Virol; 2005 Jan; 75(1):153-60. PubMed ID: 15543587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
    Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
    Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M; Abe S; Yoshioka I; Nomoto A
    Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
    Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
    Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people.
    Boot HJ; Sonsma J; van Nunen F; Abbink F; Kimman TG; Buisman AM
    Vaccine; 2007 Jun; 25(24):4706-14. PubMed ID: 17482726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering attenuated virus vaccines by controlling replication fidelity.
    Vignuzzi M; Wendt E; Andino R
    Nat Med; 2008 Feb; 14(2):154-61. PubMed ID: 18246077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.